BWA
PRCT icon

Basecamp Wealth Advisors’s Procept Biorobotics PRCT Stock Holding History

Basecamp Wealth Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Buy
580
+62
+12% +$1.55K ﹤0.01% 943
2026
Q1 		$13K Buy
518
+18
+4% +$507 ﹤0.01% 946
2025
Q4 		$15.7K Buy
+500
New +$16.6K ﹤0.01% 856

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Basecamp Wealth Advisors's PRCT Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Procept Biorobotics (PRCT) stake by 12% in Q2 2026, buying an estimated $1.55K and bringing the position to 580 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Basecamp Wealth Advisors first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $15.7K in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Basecamp Wealth Advisors held 580 shares of Procept Biorobotics worth $13.1K as of Q2 2026.
  • Basecamp Wealth Advisors bought 62 Procept Biorobotics shares in Q2 2026, an estimated $1.55K.
  • Procept Biorobotics made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #943 holding.
  • Basecamp Wealth Advisors first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Procept Biorobotics position peaked at $15.7K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.